BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2762752)

  • 1. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
    Chang TT; Lin HC; Lee SD; Tsai YT; Lee FY; Jeng FS; Wu JC; Yeh PS; Lo KJ
    Scand J Gastroenterol; 1989 Jun; 24(5):533-8. PubMed ID: 2762752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent elevation of the aminoterminal peptide of procollagen type III in serum of patients with acute viral hepatitis distinguishes chronic active hepatitis from resolving or chronic persistent hepatitis.
    Annoni G; Cargnel A; Colombo M; Hahn EG
    J Hepatol; 1986; 2(3):379-88. PubMed ID: 3722792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Procollagen III and laminin in chronic viral hepatopathies].
    Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
    Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
    Matsuda H
    Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):153-61. PubMed ID: 1851519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis.
    Trivedi P; Cheeseman P; Portmann B; Hegarty J; Mowat AP
    Eur J Clin Invest; 1985 Apr; 15(2):69-74. PubMed ID: 3922770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of the determination of the aminopropeptide of type III procollagen in patients with primary liver cancer.
    Farinati F; Annoni G; Donato MF; Nardelli P; Bertozzo A; De Maria N; Zotti S; Salvagnini M; Martinez D; Naccarato R
    J Gastroenterol Hepatol; 1990; 5(6):633-8. PubMed ID: 1966598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.
    Babić Z; Bilić A; Babić D; Jagić V; Nikolić B; Sunić M
    Wien Klin Wochenschr; 2003 May; 115(9):302-8. PubMed ID: 12793031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
    Solís-Herruzo JA; Morillas JD; Vargas J; Colina F; Castellano G; Muñoz Yagüe T; Estenoz J
    Med Clin (Barc); 1992 May; 99(1):1-5. PubMed ID: 1602891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ; Coelho-Little ME; Cheinquer H; Vargas C; Civantos F; Alvarez L; Reddy KR; Parker T; de Medina M; Li X
    Am J Gastroenterol; 1995 Sep; 90(9):1437-40. PubMed ID: 7661165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The serum concentrations of the aminoterminal propeptide of procollagen type III and the hepatic content of mRNA for the alpha 1 chain of procollagen type III in carbon tetrachloride-induced rat liver fibrogenesis.
    Hayasaka A; Koch J; Schuppan D; Maddrey WC; Hahn EG
    J Hepatol; 1991 Nov; 13(3):328-38. PubMed ID: 1725528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseases.
    Lin DY; Chu CM; Sheen IS; Liaw YF
    Dig Dis Sci; 1995 Jan; 40(1):21-7. PubMed ID: 7821112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease.
    Hayasaka A; Schuppan D; Ohnishi K; Okuda K; Hahn EG
    J Hepatol; 1990 Jan; 10(1):17-22. PubMed ID: 2307825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serial change in serum concentration of type III procollagen N-terminal peptide after TAE in hepatocellular carcinoma, and analysis of gel filtration pattern of the peptide].
    Matsuda H; Takeda Y; Ueno T; Takeda R
    Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2742-8. PubMed ID: 2560488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis.
    Teare JP; Sherman D; Greenfield SM; Simpson J; Bray G; Catterall AP; Murray-Lyon IM; Peters TJ; Williams R; Thompson RP
    Lancet; 1993 Oct; 342(8876):895-8. PubMed ID: 8105167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration of the aminoterminal procollagen type III peptide in the rat reflects early formation of connective tissue in experimental liver cirrhosis.
    Schuppan D; Dumont JM; Kim KY; Hennings G; Hahn EG
    J Hepatol; 1986; 3(1):27-37. PubMed ID: 3745883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of serum procollagen III peptide and type IV collagen in patients with biliary atresia.
    Kobayashi H; Miyano T; Horikoshi K; Tokita A
    J Pediatr Surg; 1998 Jan; 33(1):112-4. PubMed ID: 9473113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.
    Serejo F; Costa A; Oliveira AG; Ramalho F; Batista A; De Moura MC
    Dig Dis Sci; 2001 Aug; 46(8):1684-9. PubMed ID: 11508668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum procollagen type III peptide in chronic hepatitis B. Relationship to disease activity and response to interferon-alpha therapy.
    Giustina G; Fattovich G; De Paoli M; Guido M; Favarato S; Rugge M; Alberti A; Ruol A; Plebani M
    Int J Clin Lab Res; 1996; 26(1):33-6. PubMed ID: 8739853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases.
    Collazos J; Díaz F
    Clin Chim Acta; 1994 Jun; 227(1-2):37-43. PubMed ID: 7955420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.